01 1Dasami Lab
01 1CARBAMAZEPINE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2021-10-27
Pay. Date : 2021-08-18
DMF Number : 36164
Submission : 2021-09-14
Status : Active
Type : II
20
Dasami Lab Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CARBAMAZEPINE USP, with a corresponding US DMF Number 36164.
Remarkably, this DMF maintains an Active status since its submission on September 14, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 27, 2021, and payment made on August 18, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
